to buy their products. If companies aren’t successful in obtaining reimbursement approvals, their growth prospects can be reduced. Many healthcare companies are also highly dependent on Medicare ...

The Clorox Company CLX looks well poised for growth ... comfortably outperforming the broader Consumer Staples sector and the Zacks Consumer Products - Staples industry’s decline of 1.4% ...

including distributors of healthcare products, providers of basic healthcare services and owners and operators of healthcare facilities and organizations. The second group of companies is ...

Oppenheimer analyst Rupesh Parikh maintained a Buy rating ... Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products.

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer (PFE ... develops, manufactures and sells healthcare products, including innovative medicines and vaccines.

As we head into 2025, we remain optimistic about the U.S. healthcare REIT industry as it is well-poised for robust growth thanks to the aging population, rising healthcare expenditure and ...